Zheng, Wenkai, et al. “A Humanized Anti-Toll Like Receptor 4 Antibody Fab Fragment Inhibits Pro-Inflammatory Responses Induced by Lipopolysaccharide through TLR4 in Vitro and in Vivo”. The Journal of Infection in Developing Countries, vol. 19, no. 06, June 2025, pp. 913-2, doi:10.3855/jidc.20194.